Nu Skin Enterprises (NYSE:NUS) Issues FY 2019 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) updated its FY 2019 earnings guidance on Tuesday. The company provided EPS guidance of $3.20-3.35 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.30. The company issued revenue guidance of $2.48-2.52 billion, compared to the consensus revenue estimate of $2.5 billion.Nu Skin Enterprises also updated its FY19 guidance to $3.20-$3.35 EPS.

A number of brokerages recently issued reports on NUS. ValuEngine raised shares of Nu Skin Enterprises from a strong sell rating to a sell rating in a research report on Thursday, August 1st. Stifel Nicolaus set a $39.00 price target on shares of Nu Skin Enterprises and gave the company a sell rating in a report on Wednesday. Jefferies Financial Group lowered shares of Nu Skin Enterprises from a buy rating to a hold rating and set a $40.00 price target on the stock. in a report on Wednesday, July 17th. Deutsche Bank raised shares of Nu Skin Enterprises from a hold rating to a buy rating and set a $60.00 price target on the stock in a report on Wednesday, May 1st. Finally, Citigroup lowered their price target on shares of Nu Skin Enterprises from $86.00 to $52.00 and set a buy rating on the stock in a report on Thursday, July 18th. Three research analysts have rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the company’s stock. The stock has a consensus rating of Hold and an average price target of $53.25.

Nu Skin Enterprises stock traded down $1.23 on Friday, hitting $40.70. The company’s stock had a trading volume of 398,764 shares, compared to its average volume of 704,367. The stock has a market capitalization of $2.14 billion, a price-to-earnings ratio of 11.56, a P/E/G ratio of 1.05 and a beta of 0.67. The company has a current ratio of 1.86, a quick ratio of 1.10 and a debt-to-equity ratio of 0.44. The firm has a fifty day simple moving average of $43.70. Nu Skin Enterprises has a one year low of $35.03 and a one year high of $85.75.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.83 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.83. Nu Skin Enterprises had a net margin of 4.79% and a return on equity of 24.94%. The firm had revenue of $623.50 million for the quarter, compared to analyst estimates of $622.32 million. During the same quarter in the previous year, the firm posted $0.95 EPS. The business’s revenue for the quarter was down 11.5% on a year-over-year basis. On average, analysts predict that Nu Skin Enterprises will post 3.26 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 11th. Stockholders of record on Friday, August 30th will be paid a $0.37 dividend. The ex-dividend date is Thursday, August 29th. This represents a $1.48 annualized dividend and a dividend yield of 3.64%. Nu Skin Enterprises’s dividend payout ratio is presently 42.05%.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Read More: Portfolio Manager

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with's FREE daily email newsletter.